WNK2 and Langerhans cell histiocytosis: It belongs to the inflammatory myeloid tumors.[7] About 75% of LCH cases have a mutation of mitogen-activated protein kinase pathway activation.[8,9] The clinical, pathological, and imaging manifestations are diverse in LCH, which contribute to the misdiagnosis of LCH.